Short-seller Andrew Left is betting against Palantir amid a stunning 144% rally in the shares in 2025. Left says the ...

Short-seller Citron targets Palantir, arguing the AI stock is overvalued. Find out why OpenAI's valuation suggests a ...

Investing.com -- Palantir Technologies (NYSE:NASDAQ: PLTR) stock fell 2% Monday morning after short seller Citron Research ...

Palantir Technologies Inc. (PLTR) remains expensive even if it were to match OpenAI’s sky‑high $500 billion valuation metrics, said Citron Research on Monday, questioning whether the software provider ...

Andrew Left argues that investors have overhyped Palantir stock, and its valuation pales in comparison to a true AI leader ...

Warren Buffett, Michael Burry and Andrew Left may not always agree on which stocks have good valuations. The three are all ...

Citron Research says Palantir stock at $40 per share would still be an expensive AI stock to own. Wall Street recommends ...

Citron Research did not immediately respond to a request for comment from Business Insider. Correction: July 26, 2024 — An earlier version of this story misstated the status of Nikola.

Federal authorities filed charges against Andrew Left, founder of Citron Research, who they said made at least $16 million from a multiyear scheme to manipulate market prices. By Matthew Goldstein ...

Founder of Citron Research manipulated stock prices using misleading research reports that allowed him to make quick trading profits, indictment says By Dave Michaels Follow and Justin Baer ...

(Reuters) - Citron Research has taken a short position in MicroStrategy, the company said in a post on social media platform X on Thursday. Shares of the largest corporate holder of bitcoin were ...

December 03, 2024 — 01:55 pm EST Written by TheFly for TipRanks -> Citron Research stated in a post to X: “Citron pounding the table that $ NBIS is poised to be the next AI Wall Street darling.